ArticleKidney international reports2023

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy.

Omar Ragy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.